The organization was inspired to promote awareness for the disease in the wake of the former President’s diagnosis.

In an effort to promote the use of genuine products, Novo Nordisk is offering a one-time first-month offer for Wegovy at $199 ...

The biopharmaceutical sector is underpinned by a unique ecosystem that combines public funding for basic research, university ...

Heparin is a critical drug that is highly dependent on the global supply chain and is derived from a highly complex process.

Mercalis and PharmaCord announced the completion of their merger. The new company is rebranding itself as Valeris, which will ...

Since joining the Lupus Research Alliance (LRA) in 2015, Albert T. Roy has risen to the role of president and CEO. During ...

In this Pharmaceutical Executive exclusive, Bob Jansen, David Shulkin, Gen. Paul Funk (Ret.), and Maj. Gen. Dennis LeMaster ...

Across the board, oncologists are navigating a fast-changing landscape while managing full patient loads, reimbursement ...

Pharmaceutical Executive: What are the factors that are impacting the compounded semaglutide market? Ferrin Williams, PharmD: ...

With uncertainty surrounding the future of government funding, the onus is being placed on the private sector to continue ...

Clearance of ASC50 paves the way for a Phase I trial in patients with mild-to-moderate plaque psoriasis.

Deal includes VG-3927, a first-in-class TREM2 agonist aimed at advancing next-generation Alzheimer disease therapies.